Skip to main content
SpringerLink
Log in

Comment on Keeney et al.’s “Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening”

  • Letter to the Editor
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 17 July 2021

The Original Article was published on 02 April 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Keeney E, Thom H, Turner E, et al. Using a modified Delphi approach to gain consensus on relevant comparators in a cost-effectiveness model: application to prostate cancer screening. Pharmacoeconomics. 2021;39(5):589–600.

    Article  Google Scholar 

  2. O’Mahony JF, Naber SK, Normand C, et al. Beware of kinked frontiers: a systematic review of the choice of comparator strategies in cost-effectiveness analyses of human papillomavirus testing in cervical screening. Value Health. 2015;18(8):1138–51.

    Article  Google Scholar 

  3. Sanghera S, Coast J, Martin RM, et al. Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models. BMC Cancer. 2018;18(1):1–15.

    Article  Google Scholar 

  4. Adab P, McGhee SM, Yanova J, et al. Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening. Med Care. 2004;42(6):600–9.

    Article  Google Scholar 

  5. de Gelder R, Bulliard J-L, de Wolf C, et al. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. Eur J Cancer. 2009;45(1):127–38.

    Article  Google Scholar 

  6. Heijnsdijk EA, De Carvalho T, Auvinen A, et al. Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data. J Natl Cancer Inst. 2014;107(1):366.

    PubMed  Google Scholar 

Download references

Acknowledgements

The author thanks Edna Keeney for her thoughts on the issues addressed in this manuscript.

Author information

Authors and Affiliations

  1. Centre for Health Policy and Management, Trinity College Dublin, Dublin, Ireland

    James F. O’Mahony

Authors
  1. James F. O’Mahony
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James F. O’Mahony.

Ethics declarations

Funding

No funding was provided for this work.

Conflicts of Interest

James F. O’Mahony has no conflicts of interest or competing interests that are directly relevant to the content of this article.

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Availability of Data and Material

Not applicable.

Code Availability

Not applicable.

Authors’ Contributions

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Mahony, J.F. Comment on Keeney et al.’s “Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening”. PharmacoEconomics 39, 965–967 (2021). https://doi.org/10.1007/s40273-021-01061-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-021-01061-2

Search

Navigation